RXDX

Prometheus Biosciences, Inc. Common Stock
RXDX

Overview Fund Activity
Delisted

RXDX was delisted on the 15th of June, 2023.

Back to rankings

51 hedge funds and large institutions have $573M invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+2
Holders Change %
+4.08%
% of All Funds
0.9%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
6
Increased
19
Reduced
13
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$4.02M
2
PIM
2
Platinum Investment Management
Australia
$11.9M
3
LCM
3
Laurion Capital Management
New York
$4M
4
State Street
4
State Street
Massachusetts
$4.68M
5
Wells Fargo
5
Wells Fargo
California
$367K

Top Sellers

1
SCM
1
Suvretta Capital Management
New York
$11.4M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$7.14M
3
LP
3
LMR Partners
United Kingdom
$1.19M
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$17.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
$10K -$14.6K -593 -59%
Citadel Advisors
52
Citadel Advisors
Florida
– -$944K -38,438 Closed
JF
53
Jump Financial
Illinois
– -$253K -10,311 Closed
KCM
54
Kingdon Capital Management
New York
– -$204K -8,317 Closed
PAM
55
Panagora Asset Management
Massachusetts
– -$6K -245 Closed
1 2
3